A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

✍ Scribed by Matsueda, Kei; Harasawa, Shigeru; Hongo, Michio; Hiwatashi, Nobuo; Sasaki, Daisuke

• Book ID: 120649941
• Publisher: Informa plc
• Year: 2008
• Tongue: English
• Weight: 162 KB
• Volume: 43
• Category: Article
• ISSN: 0036-5521
• DOI: 10.1080/00365520802240255